Media
Cambridge researchers to improve treatment options for deadliest common cancer by understanding how it grows
Researchers at the University of Cambridge will use a new cutting-edge laboratory technique to study which proteins cause uncontrolled cell-growth in pancreatic cancer and enable the devastating disease to spread rapidly.
Over 80% of GPs fear NHS winter pressures will prevent lifesaving cancer treatment
More than 8 in 10 GPs fear that extreme pressures on the NHS this winter will prevent people with pancreatic cancer and other less survivable cancers from having lifesaving treatment, according to our latest poll.
New blood test to detect cancer
Our CEO at Pancreatic Cancer UK, Diana Jupp has provided commentary on the new blood test that aims to detect more than 50 types of cancer before symptoms arise.
Only a third of GPs have sufficient access to vital scans needed to diagnose pancreatic cancer
Only 30% of GPs have sufficient access ‘all of the time’ to vital scans needed to diagnose the deadliest common cancer - according to our latest poll.
Tony Audenshaw and The Wheelpackers
‘The Wheelpackers’, are a team made up of Emmerdale actor Tony Audenshaw and his posse of production personnel and friends.
A third of people would wait three months or more to seek GP’s help with symptoms of pancreatic cancer
Nearly a third of people in the UK (28%) would wait three months or more to seek help from their GP if they had potential symptoms of pancreatic cancer. The shocking figure – at least three times longer than recommended - is revealed in new polling for Pancreatic Cancer UK released today to coincide with the beginning of Pancreatic Cancer Awareness Month.
Help us take on ‘Britain’s Hidden Killer’
Half of pancreatic cancer patients not prescribed tablets they need to stop them starving, new research shows
We launch our new ‘Transform Lives: Prescribe’ campaign, urging the NHS to ensure everyone who could benefit from pancreatic enzyme replacement therapy is prescribed them at the point of diagnosis.
Media centre
Scotmid Co-operative partner with Pancreatic Cancer UK
Scotmid Co-operative partner with Pancreatic Cancer UK to invest in pancreatic cancer research in Scotland
A statement from our Chair of Trustees, Lynne
We’ll get through this, together.
Coronavirus (COVID-19) statement for supporters of Pancreatic Cancer UK
We are adapting to unprecedented circumstances but we won’t be deterred from our mission. We won’t stop until we have transformed the future for everyone affected by pancreatic cancer.